Targeted Technology Fund

The Targeted Technology Funds make early-stage investments in healthcare and life science companies. They favour technologies that could change how medicine is practised and improve patient outcomes. They also look at ideas that make the development or manufacture of life science products more efficient.

Products and services

• Medical devices: investment in device makers working on clinical outcomes.
• Life science tools: technologies that speed or cheapen research and production.
• Biotechnology and diagnostics: early-stage companies in both areas.
• Specialty pharmaceuticals: selective investment in drug companies.

Who it serves

Early-stage companies with technologies that can reach the market relatively fast and at lower cost, and that meet a clear market need. The fund believes this suits a healthcare climate that rewards better care at reduced expense.

Key facts

• Stage: early
• Sectors: Medical devices, life science tools, biotechnology, diagnostics and specialty pharmaceuticals